News
Global Cannabis News & Analysis | Business of Cannabis
News · page 15
- Industry Trends
Is the German Cannabis Boom Slowing Down, or Simply Normalising?
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any doubt as the engine behind Europe’s medical cannabis boom.
- Clinical Research
Rescheduling Will Reprice Medical IP, Not Retail Footprints
US cannabis rescheduling is unlikely to trigger a land grab.
- Hemp Industry
House Agriculture Committee Advances Farm Bill With No Relief for Hemp Industry
The US House Agriculture Committee has voted to advance the 2026 farm bill without adopting any provisions to delay or repeal the incoming ban on intoxicating hemp.
- Medical Cannabis
Why Medical Cannabis Clinics Should Be Knocking on Union Doors
When a crew trainer at a fast food restaurant told her manager she had recently been prescribed medical cannabis, she came prepared.
- Industry Trends
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By Dr Sebastian Marincolo, Director of Strategic Content & Editorial, Weed.de Canadian cannabis company Organigram Global has agreed to acquire Berlin’s Sanity Group for up to 227 million euros, financed in large part by a roughly 65 million Canadian dollar capital injection from its largest shareholder, British American Tobacco (BAT).
- Press releases
Cannabis Europa Launches Reimagined VIP Experience: A New Standard for Senior Decision Makers
Cannabis Europa has today unveiled a new, fully reimagined, dedicated VIP Experience focused on the needs of senior executives, investors and policymakers shaping the future of Europe’s cannabis industry.
- Clinical Research
Ananda Pharma Cleared to Begin Dosing in NHS-Backed CBD Endometriosis Trial
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution in women with endometriosis-associated pain.
- Industry Trends
Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- Clinical Research
‘You Can’t Treat What You Can’t Measure’ – The Plan to Make the Endocannabinoid System Impossible to Ignore
Across global cannabis markets, the average levels of THC content are continuing a sustained, exponential and well-documented rise.
- Prescribers & Clinics
Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market Comparison Platform
Evidena Care, one of Switzerland’s leading specialised telemedicine providers for medical cannabis, has announced the launch of a nationwide online comparison platform for prescription-based medical cannabis products.
- CBD Market
Clinical Evidence vs. Food Law: Europe’s CBD Dilemma
The CBD sector has had a turbulent few weeks on both sides of the Channel, with the European Food Safety Authority (EFSA) terminating four novel food applications, just days after announcing incredibly restrictive new safety limits.
